Your Location:
Home >
Browse articles >
Oral Chinese Patent Medicines for Hyperlipidemia: A Scoping Review of Clinical Evidence
Oral Chinese Patent Medicines for Hyperlipidemia: A Scoping Review of Clinical Evidence
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 28, Issue 8, Pages: 214-221(2022)
DOI: 10.13422/j.cnki.syfjx.20220892
Scan QR Code
Full Text(HTML)
Figs( 2 ) Tabs( 5 )
References
Publication Info
Metrics
442
Views
1062
Downloads
5
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Clinical Evidence of Treatment of Constipation with Oral Chinese Patent Medicine: A Scoping Review
Evaluation of GRADE Clinical Research Evidence of Chinese Patent Medicine Combined with Western Medicine in Treatment of Hypertension with Dyslipidemia
Clinical Evidence of Oral Chinese Patent Medicines in Treatment of Chronic Kidney Disease: A Scoping Review
Clinical Evidence of Chinese Patent Medicines in Treatment of Respiratory Diseases in Children: A Scoping Review
Oral Chinese Patent Medicines for Breast Cancer:A Scoping Review of Clinical Evidence
Related Author
XU Simin
DAI Zeqi
Li Miaomiao
WU Xue
TANG Xudong
LIAO Xing
WANG Jiaheng
LI Yukun
Related Institution
Center for Evidence-based Chinese Medicine, Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences
Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences
China Academy of Chinese Medical Sciences
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Shaanxi University of Chinese Medicine


